BioTelemetry, Inc.
1000 Cedar Hollow Road, Suite 102
Malvern
Pennsylvania
19355
United States
Tel: 888-312-2328
Fax: 610-828-8048
Website: http://www.biotelinc.com/
59 articles about BioTelemetry, Inc.
-
Philips to Acquire BioTelemetry
12/18/2020
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that they have entered into a definitive merger agreement with Royal Philips.
-
BioTelemetry, Inc. Reports Third Quarter 2020 Financial ResultsPosts Record Quarterly Revenue Amidst Rapid Recovery
10/29/2020
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended September 30, 2020.
-
BioTelemetry, Inc. to Release Third Quarter 2020 Earnings Results on October 29, 2020
10/22/2020
BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2020 earnings on Thursday, October 29 at 4:00 PM Eastern Time.
-
BioTelemetry, Inc. Reports Second Quarter 2020 Financial ResultsPosts Strong Results and Ramps Up Business Development Activity
7/30/2020
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended June 30, 2020. Company Highlights Recognized quarterly total revenue of $99.1 million Total revenue declined 11.4% year-over-year due to the impact of COVID-19 across most of our businesses Reported quarterly GAAP net i
-
BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation
7/30/2020
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced a sales agent agreement with Boston Scientific, a global medical technology leader.
-
BioTelemetry, Inc. Acquires Remote Patient Monitoring Platform from Centene SubsidiaryExpands relationship to serve Centene members
7/29/2020
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced it has acquired the On.Demand™ remote patient monitoring (RPM) and coaching platform, operated by Envolve People Care, Inc., a Centene Corporation subsidiary. This acquisition adds chronic RPM and coaching solutions to BioTelemetry’s current suite of acut
-
BioTelemetry, Inc. to Release Second Quarter 2020 Earnings Results on July 30, 2020
7/23/2020
BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2020 earnings on Thursday, July 30 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, July 30, 2020. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com . If you are unable to participate during the live webcast, an archive will be available on the w
-
BioTelemetry, Inc. Reports First Quarter 2020 Financial ResultsAnnounces Record Quarterly Revenue
5/6/2020
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the quarter ended March 31, 2020.
-
BioTelemetry, Inc. to Release First Quarter 2020 Earnings Results on May 6, 2020
4/29/2020
BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2020 earnings on Wednesday, May 6 at 4:00 PM Eastern Time.
-
BioTelemetry, Inc. to Move to Virtual-only Annual Stockholder Meeting for 2020
4/27/2020
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that its 2020 Annual Meeting of Stockholders will be held virtually, moving away from an in-person event due to the evolving nature of the COVID-19 pandemic. Virtual meeting date: Friday, May 8, 2020 Virtual meeting time: 8:30 a.m. EDT Virtual meetin
-
Biotelemetry, Inc. expands MCOT™ service to monitor life-threatening QT prolongation in COVID-19 Patients
3/25/2020
Only remote cardiac monitoring company whose proprietary connected system has FDA-approved indication to measure, analyze and report QT interval
-
BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
2/26/2020
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the quarter and year ended December 31, 2019.
-
BioTelemetry, Inc. to Release Fourth Quarter 2019 Earnings Results on February 26, 2020
2/18/2020
BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2019 earnings on Wednesday, February 26 at 4:00 PM Eastern Time.
-
BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results
11/5/2019
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the third quarter ended September 30, 2019.
-
BioTelemetry, Inc. to Release Third Quarter 2019 Earnings Results on November 5, 2019
10/29/2019
BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2019 earnings on Tuesday, November 5 at 4:00 PM Eastern Time.
-
BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018
2/13/2018
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, February 22, 2018.
-
BioTelemetry Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
11/30/2017
The study is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation, using the Apple Watch and the dedicated “Apple Heart Study” App.
-
Telcare, a Division of BioTelemetry, Announces Collaboration With Onduo in Diabetes Management Program
11/28/2017
Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.
-
BioTelemetry Reports Third Quarter 2017 Financial Results
11/8/2017
Recognized highest quarterly revenue in Company’s history of $81.0 million, a 52.7% increase over the prior year driven by the acquisition of LifeWatch AG.
-
BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017
10/31/2017
The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.